UnitedHealth Now Has $2.9 Billion Of Commercial Paper Outstanding, After None Three Months Earlier
The insurer's quarterly report also shows a 50 million-share buyback add-on and a $1.5 billion acquisition bill still owed.
UnitedHealth, the health care company behind UnitedHealthcare and Optum, had $2.9 billion of commercial paper outstanding at September 30, according to its quarterly report filed Tuesday, at a weighted-average annual rate of 3.9%. The prior quarterly report said it had none at June 30.
A quarter of heavy cash calls
Commercial paper is short-term unsecured debt sold through broker-dealers. The borrowing arrived in a quarter when the company settled forward share-repurchase contracts of up to $2.0 billion on July 1. Under those contracts the counterparty had bought 6.4 million shares at an average $312.73.
On July 2 the company closed a $3.0 billion acquisition, paying $1.5 billion in cash. The other $1.5 billion is payable within one year and was still outstanding at quarter-end.
For the nine months, UnitedHealth repurchased about 13.8 million shares at an average $359.55, spent $5.0 billion on buybacks and paid $6.2 billion in dividends. Cash flow from operations for the period was $25.1 billion, against $18.6 billion a year earlier.
Fifty million more shares to buy
The board raised the buyback authorization in November by up to 50 million shares, added to the 7.2 million left under its 2024 renewal at September 30.
Ratings and a tax fight
Outlooks on the company's senior debt are negative at Moody's, S&P Global and Fitch, and stable at A.M. Best. The company says a significant downgrade could raise borrowing costs or limit access to capital.
It is also contesting Notices of Proposed Adjustment the IRS issued March 6 over intercompany transfer pricing with a foreign subsidiary in tax years 2017 through 2020. The IRS is seeking to significantly increase taxable income, and the company says it believes its positions are properly supported and will contest them.
The debt-to-capital ratio was 41.7% at September 30, the company said in its October earnings release, against a target of about 40.0% by year-end. UnitedHealth's market value was $359.4 billion on Tuesday.
The $1.5 billion owed on the acquisition comes due within a year of the July 2 closing.
Sources
- 10-Q Filing — UnitedHealth (UNH) — SEC EDGAR
- 10-Q Filing — UnitedHealth (UNH), Q2 FY2026 filed 2026-08-10 (comparison basis) — SEC EDGAR
- Earnings release (8-K Item 2.02, earningsrelease3q26unh.htm) — UnitedHealth, filed 2026-10-13 — SEC EDGAR